BMA Stock Banco Macro SA (BMA, $95.45) Moving Average Convergence Divergence (MACD) Histogram turned positive on January 9, 2026

GET DAILY SIGNALS

Get AI intraday signals

BMA - Banco Macro SA

MACD signal

View

Odds of UP Trend

Price: $95.45

Daily change: +$0.14 (+0.15%)

Daily volume: 306.5K

Capitalization: $6.2B

Industry: Regional Banks

This is a Bullish indicator signaling BMA's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 43 similar cases where BMA's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

BMA sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for BMA moved above the 200-day moving average on December 11, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 07, 2026. You may want to consider a long position or call options on BMA as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BMA advanced for three days, in of 297 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 289 cases where BMA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for BMA turned negative on January 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BMA broke above its upper Bollinger Band on January 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BMA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 54, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BMA's P/B Ratio (1.840) is slightly higher than the industry average of (1.173). P/E Ratio (38.084) is within average values for comparable stocks, (18.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.275). Dividend Yield (0.023) settles around the average of (0.035) among similar stocks. P/S Ratio (3.042) is also within normal values, averaging (5.345).